Michael Naumann

22PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursNutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 03, 2026
Elevated caspase 3 expression correlates with severe inflammation in Crohn's disease.

|Apr 24, 2026
ALPK1 agonists: a new strategy for cancer immunotherapy.

|Apr 01, 2026
Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer.

Keren Zohar, Marco Strecker, Thomas Wartmann

|Jan 30, 2026
Enhanced ADP-heptose-dependent NF-κB activation by Helicobacter pylori CagA through cortactin-Src-dependent tyrosine phosphorylation of IKKβ.

Irshad Sharafutdinov, Nicole Tegtmeyer, Barbara Friedrich

|May 22, 2025
CYLD-TRAF6 interaction promotes ADP-heptose-induced NF-κB signaling in H. pylori infection.

Michelle C C Lim, Gunter Maubach, Michael Naumann

|Mar 28, 2025
CSN-CRL Complexes: New Regulators of Adipogenesis.

Dawadschargal Dubiel, Michael Naumann, Wolfgang Dubiel

Pageof 4

Frequent Collaborators

2 joint publications

Wolfgang Dubiel

2 joint publications

Norbert Nass

2 joint publications

Gunter Maubach

1 joint publications

Susann A Dorosz